KRISTIANA BURRELL: Open Payments
NPI 1386398337 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 30 payments from 12 companies in 2025. Trend: 2023 $471 · 2024 $352 · 2025 $647
Food & beverage: $631Education: $16
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $148 |
| ABBVIE INC. | 12 | $137 |
| Exact Sciences Corporation | 3 | $136 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Lilly USA, LLC | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Indivior Inc. | 1 | $17 |
| Insmed, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: VRAYLAR, The Cologuard Plus Collection Kit, Ozempic, INGREZZA, CAPLYTA, MOUNJARO, ABILIFY ASIMTUFII, Wegovy.
Industry payments across NC — which companies pay providers there.
